WageWorks, Inc. (WAGE)
Last closing price (Nov 25 4:00 EDT):
58.76 (-4.44%) ?
WageWorks, Inc. operates as an on-demand provider of tax-advantaged programs for consumer-directed health, and commuter and other employee spending account benefits (CDBs) in the United States. It offers healthcare flexible spending accounts (FSAs), which are employer-sponsored CDBs that enable employees to set aside pre-tax dollars to pay for eligible healthcare expenses, including co-pays, deductibles, and over-the-counter medical products, as well as vision expenses, orthodontia, medical devices, and autism treatments; and dependent care flexible spending accounts that allow employees to set aside pre-tax dollars to pay for eligible dependent care expenses, such as child care or day care expenses. The company also provides health reimbursement arrangements (HRAs) in which employers provide their employees with a specified amount of reimbursement funds that are available to help employees defray their out-of-pocket healthcare expenses comprising deductibles, co-insurance, and co-payments. In addition, it administers health savings accounts for employers that allow employee participants to invest funds to be used for qualified healthcare expenses at any time without federal tax liability or penalty. Further, the company offers commuter benefit plans consisting of qualified parking, transit passes, transportation in a commuter highway vehicle or vanpooling, and reimbursement of certain bicycle commuting expenses. Additionally, it provides Consolidated Omnibus Budget Reconciliation Act (COBRA) continuation services to employer clients to meet the employers obligation to make available continuation of coverage for participants who are no longer eligible for the employers COBRA covered benefits, which include medical, dental, vision, HRAs, and certain healthcare FSAs. The company was founded in 2000 and is headquartered in San Mateo, California.
An analyst is a professional research analyst or an Investor Wand user who issued a recommendation for a given company.
A Research Firm is a company that researches and rates stocks and publishes recommendations.
Signal is a recommendation issued by an analyst. Investor Wand considers two types of recommendations: BUY and SELL.
A signal date is a date when a BUY or SELL recommendation was issued for given security.
Initial Price is the first closing price for a specified company upon recommendation release. If the recommendation is issued in after-market hours, the Initial Price is the next day’s closing price (for a given symbol). In case of dividend distributions and stock splits, Initial Price is adjusted.
A Price Target is an analyst’s projection of a company’s stock price by the end of the recommendation period. It represents the price at which the analyst would exit his or her existing position.
Closing Date is the expiration date of a recommendation. The validity timeframe of a professional analyst’s recommendation is 12 months. Investor Wand analysts can set their recommendation timeframe to one, three, six, or 12 months.
The return on a single open recommendation is calculated as the maximum of the current return (based on the latest closing price) and the target price return, if the symbol reached the target. The return on a single closed recommendation is calculated as the maximum of the return on the closing date (at the end of recommendation timeframe) and the target price return, if the stock hit the target price. The return is adjusted for one-time events (e.g., stock splits).
|Michael Huang||Needham & Company||Buy||Aug 06, '14||45.96||Aug 06, '15||27.85%|
|Michael Huang||Needham & Company||Buy||May 09, '14||37.97||May 09, '15||54.75%|
|David Scharf||JMP Securities||Buy||Feb 21, '14||57.20||72.00||Feb 21, '15||2.73%|
|David Scharf||JMP Securities||Buy||Nov 06, '13||57.46||65.00||Nov 06, '14||13.12%|
|Michael Huang||Needham & Company||Buy||Nov 06, '13||57.46||65.00||Nov 06, '14||13.12%|
|David Grossman||Stifel Nicolaus & Company, Inc.||Buy||Nov 01, '13||54.51||61.00||Nov 01, '14||11.91%|
|David Grossman||Stifel Nicolaus & Company, Inc.||Buy||Jun 12, '13||29.66||35.00||Jun 12, '14||56.00%|
|Michael Huang||Needham & Company||Buy||May 10, '13||29.99||May 10, '14||26.61%|
|David Scharf||JMP Securities||Buy||Mar 14, '13||25.92||29.00||Mar 14, '14||134.49%|
|Michael Huang||Needham & Company||Buy||Feb 20, '13||21.25||26.00||Feb 20, '14||180.99%|
|David Grossman||Stifel Nicolaus & Company, Inc.||Buy||Aug 09, '12||14.49||18.00||Aug 09, '13||176.05%|
|David Grossman||Stifel Nicolaus & Company, Inc.||Buy||Jun 03, '12||11.52||15.00||Jun 03, '13||151.48%|
|Michael Huang||Needham & Company||Buy||Jun 03, '12||11.52||15.00||Jun 03, '13||151.48%|